Medical Devices for Tremor Suppression: Current Status and Future Directions.

assistive feeding devices electrical stimulation systems medical devices transcutaneous electrical nerve stimulation tremor wearable orthoses

Journal

Biosensors
ISSN: 2079-6374
Titre abrégé: Biosensors (Basel)
Pays: Switzerland
ID NLM: 101609191

Informations de publication

Date de publication:
30 Mar 2021
Historique:
received: 22 02 2021
revised: 18 03 2021
accepted: 24 03 2021
entrez: 3 4 2021
pubmed: 4 4 2021
medline: 18 5 2021
Statut: epublish

Résumé

Tremors are the most prevalent movement disorder that interferes with the patient's daily living, and physical activities, ultimately leading to a reduced quality of life. Due to the pathophysiology of tremor, developing effective pharmacotherapies, which are only suboptimal in the management of tremor, has many challenges. Thus, a range of therapies are necessary in managing this progressive, aging-associated disorder. Surgical interventions such as deep brain stimulation are able to provide durable tremor control. However, due to high costs, patient and practitioner preference, and perceived high risks, their utilization is minimized. Medical devices are placed in a unique position to bridge this gap between lifestyle interventions, pharmacotherapies, and surgical treatments to provide safe and effective tremor suppression. Herein, we review the mechanisms of action, safety and efficacy profiles, and clinical applications of different medical devices that are currently available or have been previously investigated for tremor suppression. These devices are primarily noninvasive, which can be a beneficial addition to the patient's existing pharmacotherapy and/or lifestyle intervention.

Identifiants

pubmed: 33808056
pii: bios11040099
doi: 10.3390/bios11040099
pmc: PMC8065649
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Références

Brain. 2000 May;123 ( Pt 5):1017-26
pubmed: 10775546
Sci Adv. 2019 Jul 03;5(7):eaaw1297
pubmed: 31281886
JAMA Neurol. 2014 Mar;71(3):291-9
pubmed: 24395393
J Neuroeng Rehabil. 2019 Jul 18;16(1):93
pubmed: 31319893
Parkinsonism Relat Disord. 2015 Jul;21(7):729-35
pubmed: 25952960
Mov Disord. 2003 Feb;18(2):191-4
pubmed: 12539214
Parkinsonism Relat Disord. 2010 Nov;16(9):604-7
pubmed: 20691629
Cochrane Database Syst Rev. 2017 Sep 14;9:CD011976
pubmed: 28905362
J Neurol Neurosurg Psychiatry. 1980 Aug;43(8):713-8
pubmed: 7431032
Curr Neurol Neurosci Rep. 2019 Aug 3;19(9):66
pubmed: 31377876
Neurology. 2006 May 23;66(10):1500-5
pubmed: 16717208
IEEE Trans Neural Syst Rehabil Eng. 2007 Sep;15(3):367-78
pubmed: 17894269
J Physiol. 1977 Nov;272(2):415-33
pubmed: 592198
Ital J Neurol Sci. 1985 Mar;6(1):75-8
pubmed: 3873445
Am J Occup Ther. 2019 Mar/Apr;73(2):7302205120p1-7302205120p9
pubmed: 30915973
J Neuroeng Rehabil. 2020 Apr 9;17(1):47
pubmed: 32272964
Brain Stimul. 2019 Jul - Aug;12(4):868-876
pubmed: 30833216
Brain Struct Funct. 2020 Sep;225(7):2177-2192
pubmed: 32748090
Med Biol Eng Comput. 2018 May;56(5):923-930
pubmed: 29101536
Mov Disord. 2001 Sep;16(5):914-20
pubmed: 11746622
Ann Biomed Eng. 1992;20(2):225-36
pubmed: 1575378
Mov Disord. 1998 Jan;13(1):5-10
pubmed: 9452318
Neurology. 2011 Nov 8;77(19):1752-5
pubmed: 22013182
J Neuroeng Rehabil. 2018 Nov 12;15(1):103
pubmed: 30419966
J Neuroeng Rehabil. 2017 Jul 14;14(1):75
pubmed: 28705167
IEEE Trans Rehabil Eng. 1999 Sep;7(3):385-8
pubmed: 10498383
Brain. 2014 Dec;137(Pt 12):3142-8
pubmed: 25367027
PLoS Comput Biol. 2019 Aug 8;15(8):e1006575
pubmed: 31393880
Pain. 2009 Sep;145(1-2):105-9
pubmed: 19535205
J Clin Psychiatry. 2001 May;62(5):367-72
pubmed: 11411820
Parkinsonism Relat Disord. 2016 Feb;23:91-4
pubmed: 26686260
Ann Biomed Eng. 1992;20(2):205-24
pubmed: 1575377
Front Psychol. 2014 Sep 23;5:1012
pubmed: 25295014
Physiol Meas. 2007 Apr;28(4):415-25
pubmed: 17395996
Front Aging Neurosci. 2019 Feb 22;11:23
pubmed: 30853908
Clin Neurophysiol. 2004 Feb;115(2):424-34
pubmed: 14744585
Am J Occup Ther. 2018 May/Jun;72(3):7203345010p1-7203345010p5
pubmed: 29689183
Expert Rev Neurother. 2018 Dec;18(12):899-901
pubmed: 30350730
Mov Disord. 2011 Sep;26(11):2088-94
pubmed: 21656852
Ann Neurol. 2011 Feb;69(2):269-81
pubmed: 21387372
Mov Disord. 2006 Aug;21(8):1114-8
pubmed: 16622851
Nat Rev Neurol. 2019 Mar;15(3):148-160
pubmed: 30683913
J Physiol. 1980 Aug;305:433-49
pubmed: 7441563
Neuromodulation. 2019 Jul;22(5):537-545
pubmed: 30701655
J Neurophysiol. 2004 Dec;92(6):3171-82
pubmed: 15295009
Arch Neurol. 2000 Aug;57(8):1194-8
pubmed: 10927801
J Neurol Sci. 2017 Oct 15;381:331-340
pubmed: 28991711
Sci Rep. 2019 Nov 11;9(1):16476
pubmed: 31712728
Top Spinal Cord Inj Rehabil. 2012 Winter;18(1):28-33
pubmed: 23459150
N Engl J Med. 2018 May 10;378(19):1802-1810
pubmed: 29742376
N Engl J Med. 2000 Feb 17;342(7):461-8
pubmed: 10675426
BMJ. 2016 Aug 16;354:i4485
pubmed: 27530225
Stud Health Technol Inform. 2017;242:741-747
pubmed: 28873879
Mov Disord. 2010 Apr 15;25(5):534-41
pubmed: 20175185
Front Bioeng Biotechnol. 2016 Mar 31;4:29
pubmed: 27066477
Tremor Other Hyperkinet Mov (N Y). 2017 Dec 18;7:526
pubmed: 29276649
Tremor Other Hyperkinet Mov (N Y). 2020 Aug 14;10:29
pubmed: 32864188
Mov Disord. 2017 Mar;32(3):325-331
pubmed: 28116753
Brain Stimul. 2019 Nov - Dec;12(6):1402-1409
pubmed: 31351911
Neurology. 2005 Jun 28;64(12):2008-20
pubmed: 15972843
Nat Med. 2015 Nov;21(11):1326-31
pubmed: 26479925
Eur J Appl Physiol. 2011 Oct;111(10):2399-407
pubmed: 21870119
Rev Pain. 2007 Aug;1(1):7-11
pubmed: 26526976
JAMA. 2014 Mar 5;311(9):948-54
pubmed: 24595779
Neuroepidemiology. 2019;52(1-2):111-118
pubmed: 30625472
Lancet Neurol. 2018 Nov;17(11):939-953
pubmed: 30287051
Mov Disord. 2014 May;29(6):838-42
pubmed: 24375570
IEEE Trans Neural Syst Rehabil Eng. 2014 Mar;22(2):379-88
pubmed: 24608690
J Rehabil Res Dev. 1995 Feb;32(1):1-16
pubmed: 7760262
J Electromyogr Kinesiol. 1993;3(3):131-48
pubmed: 20719625
J Neurol Sci. 2017 Mar 15;374:26-31
pubmed: 28088312
Mov Disord. 2018 Jan;33(1):75-87
pubmed: 29193359
J Neurol. 2013 Mar;260(3):714-40
pubmed: 22886006
J Rehabil Res Dev. 1998 Oct;35(4):373-87
pubmed: 10220215
Alzheimer Dis Assoc Disord. 2015 Apr-Jun;29(2):141-5
pubmed: 25037029
J Physiol. 1978 Dec;285:493-513
pubmed: 745115
Mov Disord. 2017 Aug;32(8):1165-1173
pubmed: 28370272
Arch Neurol. 2008 Jan;65(1):101-7
pubmed: 18195146
Expert Rev Neurother. 2018 Apr;18(4):303-321
pubmed: 29475371
Fed Regist. 2018 Oct 17;83(201):52315-6
pubmed: 30358381
Clin Pharmacol Ther. 2019 Oct;106(4):763-775
pubmed: 31179534
Parkinsonism Relat Disord. 2011 Aug;17(7):509-15
pubmed: 21632272
Soft Robot. 2020 Aug 19;:
pubmed: 32822240
J Neuropsychiatry Clin Neurosci. 2011 Spring;23(2):141-8
pubmed: 21677241
Mov Disord. 2019 Jul;34(7):950-958
pubmed: 31046186
Stereotact Funct Neurosurg. 2018;96(6):379-391
pubmed: 30654368
J Neuroeng Rehabil. 2013 Apr 15;10:36
pubmed: 23587119
Pain. 1988 Jan;32(1):89-94
pubmed: 3340426
Acta Neurochir (Wien). 2017 May;159(5):771-778
pubmed: 28258308
Cochrane Database Syst Rev. 2015 Jun 15;(6):CD006142
pubmed: 26075732
Front Neurosci. 2017 Apr 04;11:178
pubmed: 28420958
Lancet Neurol. 2011 Feb;10(2):148-61
pubmed: 21256454
Neurology. 2004 Mar 23;62(6):932-6
pubmed: 15037695
IEEE Trans Neural Syst Rehabil Eng. 2015 May;23(3):385-95
pubmed: 25051555
Cochrane Database Syst Rev. 2019 Apr 03;4:CD011890
pubmed: 30941745
Arch Phys Med Rehabil. 2006 May;87(5):661-70
pubmed: 16635629
J Neurol. 2018 May;265(5):1050-1058
pubmed: 29478221
Med Biol Eng Comput. 2011 Oct;49(10):1187-93
pubmed: 21755318
J Alzheimers Dis. 2011;23(4):727-35
pubmed: 21304183
Mov Disord. 1996 Jan;11(1):70-8
pubmed: 8771070

Auteurs

Jiancheng Mo (J)

Massachusetts College of Pharmacy and Health Sciences University, School of Pharmacy, Boston, MA 02115, USA.

Ronny Priefer (R)

Massachusetts College of Pharmacy and Health Sciences University, School of Pharmacy, Boston, MA 02115, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH